3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...

3/21/2025Rhythm Pharma Regains Rights to Obesity Drug in China

3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...

3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint

3/21/2025Forward Pharma Secures CNY 100M Financing

3/20/2025State Council Issues the Opinion on Enhancing TCM Quality and Promotin...

3/20/2025Chinese Government Issues Notice on Strengthening Drug Traceability Co...

3/20/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (92...

3/20/2025NMPA Seeks Public Feedback on Draft Guidelines for Drug Trial Data Pro...

3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China

3/19/2025Rona Thera Secures $25M in Series Pre-B Financing to Advance siRNA The...

3/19/2025Shanghai Breaks Ground on National Emergency Medical Center

3/19/2025MSD Expands Public Health Efforts in China Following HPV Vaccine Appro...

3/19/2025CDE Issues the 2024 Annual Drug Evaluation Report with Record Surge in...

3/19/2025EU Chamber Urges China to Balance Drug Procurement Priorities amid Pri...

3/19/2025Teva and Kerry Form Strategic Partnership to Strengthen Pharma Supply ...

3/19/2025Visirna's VSA001 Achieves Positive Phase III Results in Treating FCS

3/19/2025CSPC Initiates Phase 3 Trial of SYS6010 for EGFR-Mutant NSCLC Patients

3/19/2025Celregen Secures ~CNY 100M in Angel+ Financing

3/19/2025Hengrui Initiates Phase 2/3 Trial Combining SHR-A2102 and Adebrelimab ...

3/19/2025Accropeutics Secured $12M in Series B Plus Financing

3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...

3/17/2025Visirna Announce Positive Topline Results from Phase 3 Trial of Ploza...

3/17/2025NMPA Solicits Comments on Draft Revision of GMP Annex for Sterile Drug...

3/17/2025China Suspends Imports of Five APIs from Kyowa Hakko Bio's Hofu Plant

3/17/2025SinoCellTech Advances PD-1/VEGF Bispecific SCTB14 into Phase 2/3 for E...

3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China

3/17/2025HBM and Insilico Enter Strategic Deal to Advance AI-Driven Antibody Di...

3/14/2025Recent Executive Moves

3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...

Page:7/48 Total number of articles:1430: [First][<<] [5] [6] [7] [8] [9] [>>] [End]